API
TECH icon

Advisor Partners II’s Bio-Techne TECH Stock Holding History

Advisor Partners II’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$243K Hold
3,566
– – 0.01% 1070
2023
Q2 		$291K Buy
3,566
+537
+18% +$43.2K 0.01% 804
2023
Q1 		$225K Buy
3,029
+135
+5% +$10.4K 0.01% 876
2022
Q4 		$240K Buy
+2,894
New +$230K 0.01% 771

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisor Partners II's TECH Position: Q3 2023 in Review

Advisor Partners II held its Bio-Techne (TECH) position steady in Q3 2023 at 3,566 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #1070.

Advisor Partners II first reported a position in TECH in Q4 2022 and has held it in 4 quarters since. The position peaked at $291K in Q2 2023. 529 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • Advisor Partners II held 3,566 shares of Bio-Techne worth $243K as of Q3 2023.
  • Advisor Partners II left its Bio-Techne share count unchanged in Q3 2023.
  • Bio-Techne made up 0.01% of Advisor Partners II's portfolio in Q3 2023, its #1070 holding.
  • Advisor Partners II first reported a position in Bio-Techne in Q4 2022 and has held it in 4 quarters since.
  • Advisor Partners II's Bio-Techne position peaked at $291K in Q2 2023.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.